The trial led by scientists at the Melanoma Institute of Australia has presented data that establishes that long-term disease ...

A groundbreaking Australian clinical trial has shown that a majority of melanoma patients whose cancer has spread to the ...

The leading Advanced Melanoma Companies such as OncoSec Medical, Immunocore, Sanofi, TILT Biotherapeutics, Novartis ...

A combination immunotherapy may help cure a majority of patients with melanoma -- a deadly skin cancer -- that has spread to ...

Melanoma is one of the most aggressive skin cancers, with more than 300,000 new cases reported worldwide each year. In Europe ...

The FDA granted fast track status to IBI363 for the treatment of patients with advanced squamous lung cancer after prior ...

The clinical trials are sponsored by IO Biotech and conducted in collaboration with Merck, which is supplying pembrolizumab. IO Biotech maintains global commercial rights to Cylembio. KEYTRUDA ® is a ...

Melanoma is one of the most aggressive skin cancers, with over 300,000 new cases reported worldwide each year. In Europe, the number of diagnoses has been rising rapidly.

During a Case-Based Roundtable® event, Evan J. Lipson, MD, moderated a discussion on the tolerability of immunotherapy in ...

Upon Opdualag’s approval in 2022 as a first-in-class cancer immunotherapy, Bristol Myers Squibb was anxious to explore its potential in a variety of indications. | Bristol Myers Squibb is striking out ...

Radiotherapy for advanced melanoma aims to relieve symptoms and improve a person’s quality of life. Where the cancer has spread to is called a metastasis or secondary cancer. If there are a small ...

Professor Georgina Long from the Melanoma Institute Australia said of 36 terminal patients given the combination therapy, ...